Liver Disease Liver Diseases Acting Career Production Clinical Trials Health Risks Social Media Influencers Content Creation Liver Transplant
The deal, which could reach $2 billion with milestones, positions GSK to target unmet needs in liver disease with a planned 2029 launch.